MedTrace Logo

Facial Skin Health Tracking Feasibility in Breast Cancer Patients

NCT04035408 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-09-05

No results posted yet for this study

Summary

This feasibility study will assess if tracking objective and subjective facial skin changes over time is acceptable to pre and perimenopausal women undergoing chemotherapy and/or endocrine therapy for breast cancer. There is no intervention arm and no control group. Skin health will be assessed through the instruments described below, and subjective data will be collected with self-administered questionnaires.

Conditions

  • Breast Cancer Female

Interventions

OTHER

Skin health assessment

Assess and measure the natural history of facial skin changes in pre and perimenopausal women undergoing chemotherapy and/or endocrine therapy for breast cancer

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-24
Primary Completion
2023-02-13
Completion
2023-02-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04035408 on ClinicalTrials.gov